Search

Your search keyword '"Pablo Garcia-Pavia"' showing total 73 results

Search Constraints

Start Over You searched for: Author "Pablo Garcia-Pavia" Remove constraint Author: "Pablo Garcia-Pavia"
73 results on '"Pablo Garcia-Pavia"'

Search Results

1. Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA‐HCM

2. Age- and Sex-Related Differences in Patients With Wild-Type Transthyretin Amyloidosis

3. Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey

4. A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)

5. A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis

6. Case report: Alternative approach for management of refractory volume overload in heart failure: usefulness of venous leg compression

7. Non-invasive assessment of HFpEF in mouse models: current gaps and future directions

8. World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

9. Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy

10. AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor

11. Role of Early Assesment of Diuresis and Natriuresis in Detecting In-Hospital Diuretic Resistance in Acute Heart Failure

12. Negative screening of Fabry disease in patients with conduction disorders requiring a pacemaker

13. Saw-Tooth Cardiomyopathy

14. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas

15. Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.

16. Reversible dilated cardiomyopathy: into the thaumaturgy of the heart - Part 2

17. Reversible dilated cardiomyopathy: into the thaumaturgy of the heart - Part 1

18. Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms

19. AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor

20. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

21. Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis

22. Natural History of MYH7-Related Dilated Cardiomyopathy

23. 77 HELIOS-A: 18-MONTH EXPLORATORY CARDIAC RESULTS FROM THE PHASE 3 STUDY OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS

25. Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in Spain

27. Genetic Architecture of Acute Myocarditis and the Overlap with Inherited Cardiomyopathy

28. Systemic embolism in amyloid transthyretin cardiomyopathy

29. Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy

30. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

31. Efficacy And Safety Of Aficamten In Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From The Randomized Evaluation Of Dosing With Ck-3773274 In Hypertrophic Cardiomyopathy Open Label Extension Study

33. LONG-TERM EFFICACY AND SAFETY OF AFICAMTEN IN PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

35. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator

36. Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy

37. Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey

38. Abstract 10960: Genetic Overlap of Acute Myocarditis and Inherited Cardiomyopathy

39. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

40. Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS

41. Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European Registry

43. Usefulness of natriuresis to predict in-hospital diuretic resistance

44. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

45. The cardiomyopathy of cystic fibrosis: a modern form of Keshan disease

46. Left ventricular non-compaction: genetics and embryology

47. Correlation Between Fibrosis and Malignant Arrhythmias in a Multicenter Cohort of Patients with Left Ventricular Arrhythmogenic Cardiomyopathy

48. Predicting Left Ventricular Ejection Fraction Decline in Patients with Excessive Trabeculation of the Left Ventricle and Risk of Future Major Cardiovascular Events

49. Predictive Risk Score for Ventricular Arrhythmias in a Multicenter Cohort of Left Ventricular Arrhythmogenic Cardiomyopathy Patients

Catalog

Books, media, physical & digital resources